Brief: XORTX Announces Update For Discussion With The FDA
19/03/2025 11:05
March 19 (Reuters) - XORTX Therapeutics Inc XRTX.V: XORTX ANNOUNCES UPDATE FOR DISCUSSION WITH THE FDA XORTX THERAPEUTICS INC - TO PROVIDE TYPE B MEETING PACKAGE TO FDA XORTX THERAPEUTICS INC: TYPE B MEETING DISCUSSION TO ACCELERATE XRX-026 FOR GOUT TO NDA Source text: ID:nGNX5TrTrF Further company coverage: XRTX.V ((Reuters.Briefs@thomsonreuters.com))
Recent news on XORTX Therapeutics
See all newsBrief: Xortx Outlines Anticipated Health Canada Clinical Trial Application For Xrx-026 For Gout
Brief: XORTX Therapeutics Announces Initiation Of Drug And Tablet Manufacturing For XRx-026 Program
Brief: Xortx Announces Termination And Postponement Of Investor Relations Program
Brief: XORTX Announces Director Resignation
Brief: Xortx Announces Us$5 Million Public Offering